Literature DB >> 19689420

Brown recluse spider venom: proteomic analysis and proposal of a putative mechanism of action.

Lucilene D dos Santos1, Nathalia B Dias, José Roberto, A S Pinto, Mario S Palma.   

Abstract

Loxosceles intermedia spider venom was subjected to proteomic analysis through a MudPIT shot-gun approach to identify the protein composition. Were identified 39 proteins which seem to responsible by the lesion of different types of tissues, to some physiopathological actions and by the prevention of structural damage to the toxin structures.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19689420     DOI： 10.2174/092986609788923383

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN： 0929-8665            Impact factor:   1.890


  12 in total

1.  A randomized controlled trial of trypsin to treat brown recluse spider bites in Guinea pigs.

Authors:  Wyman W Cabaniss; Sean Bush; Dorcas P O'Rourke; Paul F Fletcher; Kori L Brewer; Kvin Lertpiriyapong; Mohan Punja; Susan N Miller; William J Meggs
Journal:  J Med Toxicol       Date:  2014-09

2.  Parasitoid Jewel Wasp Mounts Multipronged Neurochemical Attack to Hijack a Host Brain.

Authors:  Ryan Arvidson; Maayan Kaiser; Sang Soo Lee; Jean-Paul Urenda; Christopher Dail; Haroun Mohammed; Cebrina Nolan; Songqin Pan; Jason E Stajich; Frederic Libersat; Michael E Adams
Journal:  Mol Cell Proteomics       Date:  2018-10-06       Impact factor: 5.911

Review 3.  Brown spider (Loxosceles genus) venom toxins: tools for biological purposes.

Authors:  Olga Meiri Chaim; Dilza Trevisan-Silva; Daniele Chaves-Moreira; Ana Carolina M Wille; Valéria Pereira Ferrer; Fernando Hitomi Matsubara; Oldemir Carlos Mangili; Rafael Bertoni da Silveira; Luiza Helena Gremski; Waldemiro Gremski; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2011-03-22       Impact factor: 4.546

4.  Transcriptome Analysis to Understand the Toxicity of Latrodectus tredecimguttatus Eggs.

Authors:  Dehong Xu; Xianchun Wang
Journal:  Toxins (Basel)       Date:  2016-12-20       Impact factor: 4.546

Review 5.  Highlights in the knowledge of brown spider toxins.

Authors:  Daniele Chaves-Moreira; Andrea Senff-Ribeiro; Ana Carolina Martins Wille; Luiza Helena Gremski; Olga Meiri Chaim; Silvio Sanches Veiga
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-02-08

6.  A multi-protease, multi-dissociation, bottom-up-to-top-down proteomic view of the Loxosceles intermedia venom.

Authors:  Dilza Trevisan-Silva; Aline V Bednaski; Juliana S G Fischer; Silvio S Veiga; Nuno Bandeira; Adrian Guthals; Fabricio K Marchini; Felipe V Leprevost; Valmir C Barbosa; Andrea Senff-Ribeiro; Paulo C Carvalho
Journal:  Sci Data       Date:  2017-07-11       Impact factor: 6.444

7.  Loxosceles gaucho Spider Venom: An Untapped Source of Antimicrobial Agents.

Authors:  Paula J Segura-Ramírez; Pedro I Silva Júnior
Journal:  Toxins (Basel)       Date:  2018-12-06       Impact factor: 4.546

Review 8.  Prospective Use of Brown Spider Venom Toxins as Therapeutic and Biotechnological Inputs.

Authors:  Luiza Helena Gremski; Fernando Hitomi Matsubara; Nayanne Louise Costacurta Polli; Bruno Cesar Antunes; Pedro Henrique de Caires Schluga; Hanna Câmara da Justa; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Front Mol Biosci       Date:  2021-06-17

Review 9.  Biotechnological Trends in Spider and Scorpion Antivenom Development.

Authors:  Andreas Hougaard Laustsen; Mireia Solà; Emma Christine Jappe; Saioa Oscoz; Line Præst Lauridsen; Mikael Engmark
Journal:  Toxins (Basel)       Date:  2016-07-23       Impact factor: 4.546

Review 10.  Forty Years of the Description of Brown Spider Venom Phospholipases-D.

Authors:  Luiza Helena Gremski; Hanna Câmara da Justa; Thaís Pereira da Silva; Nayanne Louise Costacurta Polli; Bruno César Antunes; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2020-03-06       Impact factor: 4.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.